Children's Health Defense Doctors in Japan who documented the first known biopsy-proven instance of inflammatory dilated cardiomyopathy — a condition where the heart becomes enlarged and weakened due to inflammation — following COVID-19 vaccination said their case study demonstrates the value of advanced diagnostic techniques in identifying and understanding vaccine-related side effects.
A case study from Japan has documented the first known biopsy-proven instance of inflammatory dilated cardiomyopathy (iDCM) — a condition where the heart becomes enlarged and weakened due to inflammation — following COVID-19 vaccination.
Doctors at Narita-Tomisato Tokushukai Hospital in Chiba, Japan, used an endomyocardial biopsy to diagnose iDCM in a 78-year-old woman who developed heart problems after receiving her third COVID-19 vaccine dose.
The patient had previously received two doses of the Pfizer-BioNTech BNT162b2 mRNA vaccine, followed by a Moderna mRNA-1273 booster.
The case, reported on July 1 in a peer-reviewed open-access article in the journal ESC Heart Failure, marks a significant advancement in understanding potential cardiac complications related to COVID-19 vaccines.
…
Read Full Article Here…(childrenshealthdefense.org)
Home | Caravan to Midnight (zutalk.com)
Live Stream + Chat (zutalk.com)
Be First to Comment